Page last updated: 2024-12-08

4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol: RN given refers to (3beta,5alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

14-demethyllanosterol : A 3beta-sterol formed formally by loss of a methyl group from the 14-position of lanosterol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID165609
CHEBI ID18364
SCHEMBL ID188095
MeSH IDM0061301

Synonyms (18)

Synonym
4,4-dimethylcholesta-8(9),24-dien-3beta-ol
4,4-dimethylzymosterol
(3beta,5alpha)-4,4-dimethylcholesta-8,24-dien-3-ol
14-desmethyllanosterol
CHEBI:18364
4,4-dimethyl-5alpha-cholesta-8,24-dien-3beta-ol
14-demethyllanosterol
7448-02-4
4,4-dimethyl-8,24-cholestadienol
17-(1,5-dimethylhex-4-enyl)-4,4,10,13-tetramethyl-2,3,4,5,6,7, 10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a] phenanthren-3-ol
4,4-dimethylcholesta-8,24-dien-3-ol
LMST01010176
(3s,5r,10s,13r,14r,17r)-4,4,10,13-tetramethyl-17-[(2r)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol
cholesta-8,24-dien-3-ol, 4,4-dimethyl-, (3beta,5alpha)-
SCHEMBL188095
4,4-dimethyl-5alpha-cholesta-8,24-diene-3beta-ol
Q27103032

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Gene dosage experiments using the sphingolipid long chain sphingoid base (LCB) hydroxylase gene, SUR2, suggest that erg26-1 cells may accumulate LCB, thus placing one point of sterol regulation of sphingolipid synthesis possibly at the level of ceramide metabolism."( Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae.
Baudry, K; Germann, M; McDonough, V; Nickels, JT; Stukey, J; Swain, E, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of lipids500463
Metabolism of steroids111135
Cholesterol biosynthesis2249
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways039
Cholesterol biosynthesis with skeletal dysplasias014
Cholesterol biosynthesis pathway in hepatocytes1137
Ergosterol biosynthesis332
superpathway of ergosterol biosynthesis I2156
zymosterol biosynthesis826
cholesterol biosynthesis I944
cholesterol biosynthesis III (via desmosterol)939
superpathway of cholesterol biosynthesis2178
superpathway of ergosterol biosynthesis2256

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.06 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]